TII
26.10.2021 10:21:09 CEST | Business Wire | Press release
Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), today announced that its Secure Systems Research Centre (SSRC) has partnered with three prestigious universities on secure mesh communications research projects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211026005550/en/
Mesh network is a network topology in which the infrastructure nodes connect directly, dynamically, and non-hierarchically to as many other nodes as possible, and cooperate with one another to efficiently route data to and from third parties. The project is set to strengthen the security of the Mesh network technology that TII is currently developing for machine to machine and human to human communications.
The three partner universities include the UAE’s Khalifa University of Science and Technology , a world-class research institution that nurtures critical thinkers in applied science and engineering, University of Turku in Turku, Finland, and Graz University of Technology (TU Graz) in Styria, Austria. The Khalifa University project is titled ‘A Secure and Resilient Chat/VoIP Application over Private Mesh Networks’. Meanwhile, the University of Turku project focuses on ‘R3Swarms: Robust, Resilient and Reconfigurable Swarms’, and the project with TU Graz is titled ‘SPiDR: Secure, Performant, Dependable, and Resilient Wireless Mesh Networks’.
Speaking on the significance of this development for the UAE and the wider region, Dr Shreekant (Ticky) Thakkar, Chief Researcher at SSRC , said: “In the UAE we conduct research to provide technology that improves life through making systems and communications safer. This is of the utmost importance when technologies combine human, physical systems, and software interactions. Mesh Network Research conducted with our partners in Turku University, TU Graz, and Khalifa University will accelerate the deployment of safe communication for the benefit of people living in the UAE and the wider region.”
Dr Thakkar said the collaborations with Turku University and TU Graz will span the domain of communication resilience improvement through exploring, among other aspects, UWB (Ultra-wideband) transmissions, while the partnership with Khalifa University focuses on PHY (Physical layer) security and secure routing. A total of four research programmes are getting underway to provide a significant improvement in the ability of Mesh Networks to resist eavesdropping, scanning, malware propagation and jamming, among other threats. As a direct application, these benefits are critical for cyber physical system swarm communications to become credible and resilient when operating autonomously, Dr Thakkar added.
He noted that dependable and secure Mesh Networks are an integral part of overall communication infrastructure and will enable secure autonomous systems.
Dr Carlo Boano, Associate Professor, Institute of Technical Informatics, TU Graz, said: “The technologies developed within SPiDR will empower off-the-shelf drones and smartphones with the ability to autonomously detect and mitigate malicious attacks and coexistence problems, thereby increasing their availability and functionality without adding to the costs of operating them.”
Dr Tomi Westerlund, Associate Professor, Smart Systems at University of Turku, said: “The project with SSRC focuses on exploiting and advancing state-of-the-art technologies including, but not limited to, DL, DLT, and UWB, as the basis to design and build more secure, flexible, robust, resilient, and reconfigurable swarms.”
For his part, Dr Hadi Otrok, Associate Professor, Department of Electrical Engineering and Computer Science at Khalifa University, said: “Through this project, we aim to build efficiencies and address earlier shortcomings by developing efficient chat and VoIP applications within secure and resilient Mesh Networks.”
For more information, visit www.tii.ae
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20211026005550/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
Ant International Launches Industry's First Full-Stack AI-Native Solutions for Payment, Account, FX, Treasury and Growth Operations for Global Businesses18.9.2026 08:53:00 CEST | Press release
In its largest-ever product upgrade, the company unveils an industry-first AI-native, end-to-end full financial stack with close to 100 key products across 4 business pillars.Built on newly upgraded Antom 3-in-1 Transformer, our payment foundation model, and FalconTST, our AI FX & liquidity forecast model.Underpinned by an agent-ready, 2-layered trust and security framework, and a governance-by-design approach that keeps us aligned with evolving compliance and regulatory environments.Autopilots for payment, account and treasury management embedded in the end-to-end financial stack to manage the five main workstreams in natural-language interaction.Introduces agent-native solutions including world's first Account for Agent (AFA) for businesses.89.5% of clients of our main merchant payment service already deployed our FinAI solutions in past 12 months. 81.4% of payment tasks were completed with AI help. In an industry first, Ant International launched a full stack of AI-native solutions
Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems18.9.2026 07:00:00 CEST | Press release
2026 Awardees are Corus International,Humanity & Inclusion Handicap International, Kwame Nkrumah University of Science and Technology (KNUST) and Terre des hommes Foundation (Tdh)Commitment of USD 22.2 Million Increases Takeda’s Total Global CSR Program Contributions to USD 260.9 Million Across 42 Diverse Collaborations Worldwide, With 20 Currently Ongoing in 42 Countries Takeda (TSE:4502/NYSE: TAK) announced that it has awarded a total of USD 22.2 million to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to supporting climate-resilient health systems in low- and middle-income countries around the world and aligned with the company’s purpose of better health for people, brighter future for the world. As climate change, extreme weather events and shifting global aid priorities continue to challenge healthcare access, Takeda is advancing its 2026 collaborations with the goal of expanding equitable access, strengthening health sy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
